Allen Horhota
About Allen Horhota
Allen Horhota is a Senior Director and Head of Delivery with a PhD in Chemistry, specializing in nucleic acid backbones and their applications in nanoparticle delivery systems.
Senior Director, Head of Delivery at Moderna
Allen Horhota is the Senior Director, Head of Delivery at Moderna. In this leadership role, he oversees the development and implementation of delivery mechanisms for various pharmaceutical products. His responsibilities likely include leading teams to enhance the efficiency and effectiveness of delivery processes, ensuring that these delivery methods meet clinical and commercial standards.
PhD in Chemistry from Boston College
Allen Horhota earned his PhD in Chemistry at Boston College. His specialization was in the field of simplified nucleic acid backbones, focusing on their chemical synthesis and enzymatic processing. This advanced training provides him with a deep understanding of the molecular structures and processes crucial for developing delivery systems in the pharmaceutical and biotechnology sectors.
Publications and Patents in Nucleic Acid and Nanoparticle Delivery
Allen Horhota is an author on multiple papers and patents in the fields of nucleic acids, nanoparticle targeting, and polymeric and lipid nanoparticle delivery of RNA. His contributions to these academic and industrial publications help advance the knowledge and technology in these specialized areas, reflecting his expertise and active involvement in cutting-edge research.
Contributions to Moderna and BIND Therapeutics
Allen Horhota has made significant contributions to several clinical and commercial nanoparticle programs at Moderna and BIND Therapeutics. At Moderna, he played a key role in the Delivery Innovation group, focusing on developing novel materials and processes to improve mRNA delivery. At BIND Therapeutics, he held various scientific and leadership roles, focusing on active nanoparticle targeting and processing techniques to enable small molecule and nucleic acid payloads.